Susquehanna International Group, LLP Nevro Corp Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $1,884 - $4,040	400 Added 0.35%	115,400 $643,000
Q2 2024 Aug 15, 2024	BUY	$7.96 - $13.59 $678,192 - $1.16 Million	85,200 Added 285.91%	115,000 $968,000
Q1 2024 May 07, 2024	SELL	$13.56 - $20.78 $1.49 Million - $2.28 Million	-109,900 Reduced 78.67%	29,800 $430,000
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $1.44 Million - $2.27 Million	101,700 Added 267.63%	139,700 $3.01 Million
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $420,882 - $597,135	-23,100 Reduced 37.81%	38,000 $730,000
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $841,464 - $1.46 Million	37,200 Added 155.65%	61,100 $1.55 Million
Q1 2023 May 16, 2023	BUY	$30.17 - $41.11 $555,128 - $756,424	18,400 Added 334.55%	23,900 $863,000
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $608,381 - $824,980	-16,700 Reduced 75.23%	5,500 $217,000
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $902,651 - $1.18 Million	22,200 New	22,200 $1.04 Million
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $335,720 - $515,536	-5,600 Reduced 27.45%	14,800 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $883,662 - $1.32 Million	-10,900 Reduced 34.82%	20,400 $1.65 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $224,378 - $365,992	2,200 Added 7.56%	31,300 $3.64 Million
Q2 2021 Aug 11, 2021	BUY	$141.6 - $179.06 $1.98 Million - $2.51 Million	14,000 Added 92.72%	29,100 $4.82 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $1.14 Million - $1.57 Million	-8,600 Reduced 36.29%	15,100 $2.11 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $3.54 Million - $4.72 Million	-25,600 Reduced 51.93%	23,700 $4.1 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $4.54 Million - $5.79 Million	-39,800 Reduced 44.67%	49,300 $6.87 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $1.54 Million - $2.23 Million	-17,200 Reduced 16.18%	89,100 $10.6 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $203,667 - $418,499	2,900 Added 2.8%	106,300 $10.6 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $5.05 Million - $7.77 Million	-66,100 Reduced 39.0%	103,400 $12.2 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $2.12 Million - $3.13 Million	34,400 Added 25.46%	169,500 $14.6 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $4.2 Million - $4.84 Million	72,300 Added 115.13%	135,100 $8.76 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $5.47 Million - $9.64 Million	-154,000 Reduced 71.03%	62,800 $3.93 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $4.77 Million - $7.58 Million	134,700 Added 164.07%	216,800 $8.43 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $2.4 Million - $4.09 Million	54,200 Added 194.27%	82,100 $4.68 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $1.53 Million - $1.96 Million	21,200 Added 316.42%	27,900 $2.23 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $1.56 Million - $1.98 Million	-22,400 Reduced 76.98%	6,700 $581,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $3.67 Million - $5.2 Million	-55,700 Reduced 65.68%	29,100 $2.01 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $6.86 Million - $7.72 Million	84,800	84,800 $7.71 Million

Others Institutions Holding NVRO

# of Institutions

150

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$19.8 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$16.9 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$16.3 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$11 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$9.47 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account